Earnings Call · Q2 FY2023·2023-08-06

Q2 23EPS -31.25%·Rev n/aQ1 23EPS -21.05%·Rev n/aQ4 22EPS 0.00%·Rev n/aQ3 22EPS -63.16%·Rev n/a⚠ consensus missing

FENNEC PHARMACEUTICALS INC. FENC

Robert Andrade — Chief Financial Officer

Rostislav Raykov — Chief Executive Officer

Adrian Haigh — Chief Operating Officer

+0.2%1d on move date+0.7% vs SPY3d+1.7%5d+4.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FENC calls or request research access.

More FENC calls Browse calls Request research access